Tandem Diabetes Care (TNDM) Non-Current Assets (2013 - 2026)
Tandem Diabetes Care posted quarterly Non-Current Assets of $266.3 million for Q1 2026, up 2.93% year-on-year from $258.7 million in Q1 2025, and up 1.26% on a QoQ basis from $263.0 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Non-Current Assets data on file, last reported at $266.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 2.93% year-over-year to $266.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 15.04% YoY), and the FY2025 full-year result was $263.0 million, up 8.14% from the prior year.
- Non-Current Assets for Q1 2026 stood at $266.3 million, up from $263.0 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $266.3 million in Q1 2026 and bottomed at $181.8 million in Q3 2023.
- The 5-year median for Non-Current Assets is $204.9 million (2024), against an average of $220.2 million.
- The widest annual swing landed in 2022, when Non-Current Assets jumped 123.66%; it then fell 14.75% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $202.8 million in 2022, then increased by 0.92% to $204.7 million in 2023, then rose by 18.81% to $243.2 million in 2024, then grew by 8.14% to $263.0 million in 2025, then grew by 1.26% to $266.3 million in 2026.
- The last three Non-Current Assets figures came in at $266.3 million (Q1 2026), $263.0 million (Q4 2025), and $257.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 266.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266.29 Mn |
| Dec 31, 2025 | 262.97 Mn |
| Sep 30, 2025 | 257.71 Mn |
| Jun 30, 2025 | 260.92 Mn |
| Mar 31, 2025 | 258.71 Mn |
| Dec 31, 2024 | 243.17 Mn |
| Sep 30, 2024 | 204.90 Mn |
| Jun 30, 2024 | 204.12 Mn |
| Mar 31, 2024 | 205.85 Mn |
| Dec 31, 2023 | 204.67 Mn |
| Sep 30, 2023 | 181.77 Mn |
| Jun 30, 2023 | 182.37 Mn |
| Mar 31, 2023 | 196.23 Mn |
| Dec 31, 2022 | 202.81 Mn |
| Sep 30, 2022 | 213.22 Mn |
| Jun 30, 2022 | 201.53 Mn |
| Mar 31, 2022 | 196.81 Mn |
| Dec 31, 2021 | 93.62 Mn |
| Sep 30, 2021 | 95.33 Mn |
| Jun 30, 2021 | 96.97 Mn |
| Mar 31, 2021 | 92.58 Mn |
| Dec 31, 2020 | 79.18 Mn |
| Sep 30, 2020 | 80.70 Mn |
| Jun 30, 2020 | 76.56 Mn |
| Mar 31, 2020 | 62.45 Mn |
| Dec 31, 2019 | 49.97 Mn |
| Sep 30, 2019 | 46.05 Mn |
| Jun 30, 2019 | 41.93 Mn |
| Mar 31, 2019 | 28.67 Mn |
| Dec 31, 2018 | 18.41 Mn |
| Sep 30, 2018 | 18.94 Mn |
| Jun 30, 2018 | 29.65 Mn |
| Mar 31, 2018 | 30.36 Mn |
| Dec 31, 2017 | 31.19 Mn |
| Sep 30, 2017 | 31.99 Mn |
| Jun 30, 2017 | 33.41 Mn |
| Mar 31, 2017 | 32.78 Mn |
| Dec 31, 2016 | 20.30 Mn |
| Sep 30, 2016 | 19.35 Mn |
| Jun 30, 2016 | 18.31 Mn |
| Mar 31, 2016 | 18.08 Mn |
| Dec 31, 2015 | 17.74 Mn |
| Sep 30, 2015 | 17.60 Mn |
| Jun 30, 2015 | 17.28 Mn |
| Mar 31, 2015 | 15.98 Mn |
| Dec 31, 2014 | 15.71 Mn |
| Sep 30, 2014 | 15.52 Mn |
| Jun 30, 2014 | 15.59 Mn |
| Mar 31, 2014 | 14.03 Mn |
| Dec 31, 2013 | 13.23 Mn |